Naso-maxillary non-Hodgkin lymphoma associated with methotrexate treatment in a patient with rheumatoid arthritis

J Oral Maxillofac Surg. 2006 Apr;64(4):708-11. doi: 10.1016/j.joms.2005.12.029.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Bleomycin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Leucovorin / administration & dosage
  • Lymphoma, B-Cell / chemically induced*
  • Lymphoma, B-Cell / drug therapy
  • Maxillary Neoplasms / chemically induced*
  • Maxillary Neoplasms / drug therapy
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Nose Neoplasms / chemically induced*
  • Nose Neoplasms / drug therapy
  • Prednisone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Antirheumatic Agents
  • Bleomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Leucovorin
  • Prednisone
  • Methotrexate

Supplementary concepts

  • MACOP-B protocol